Eli Lilly to cut 250 jobs at France plant, through voluntary redundancy
PARIS (Reuters) - Pharmaceutical group Eli Lilly said on Tuesday it will cut 250 jobs at its factory located near Strasbourg in Eastern France.
The company said it will reduce its payroll at the plant through a voluntary redundancy plan.
Eli Lilly currently employs 1,400 workers at the plant.
JANUARY 8, 2019https://www.reuters.com/
AstraZeneca and Ionis build case for amyloidosis drug eplontersen
AstraZeneca and Ionis are waiting for an FDA decision on their new therapy for one of the complications of the disease transthyretin amyloidosis (ATTR) later this year, and now have new data sugges...
AbbVie Hits Snag for Parkinson’s Disease Candidate
The FDA said it could not approve AbbVie’s new drug application (NDA) for ABBV-951 (foslevodopa/foscarbidopa), an investigational therapy for advanced Parkinson’s disease, because of concerns a...
FDA Approves Sandoz’s Citrate-Free Adalimubab Formulation
The FDA has approved Sandoz’s citrate-free high-concentration formulation of its biosimilar Hyrimoz (adalimumab-adaz) injection for seven of the approved indications of AbbVie’s Humira (adalimu...